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Aim: The increase in skeletal muscle fatty acid metabolism during exercise
has been associated with the release of calcium. We examined whether this
increase in fatty acid oxidation was attributable to a calcium-induced
translocation of the fatty acid transporter CD36 to the sarcolemma,
thereby providing an enhanced influx of fatty acids to increase their oxida-
tion.
Methods: Calcium release was triggered by caffeine (3 mM) to examine
fatty acid oxidation in intact soleus muscles of WT and CD36-KO mice,
while fatty acid transport and mitochondrial fatty acid oxidation were
examined in giant vesicles and isolated mitochondria, respectively, from
caffeine-perfused hindlimb muscles of WT and CD36-KO mice. Western
blotting was used to examine calcium-induced signalling.
Results: In WT, caffeine stimulated muscle palmitate oxidation (+136%),
but this was blunted in CD36-KO mice (70%). Dantrolene inhibited
(WT) or abolished (CD36-KO) caffeine-induced palmitate oxidation. In
muscle, caffeine-stimulated palmitate oxidation was not attributable to
altered mitochondrial palmitate oxidation. Instead, in WT, caffeine
increased palmitate transport (+55%) and the translocation of fatty acid
transporters CD36, FABPpm, FATP1 and FATP4 (26–70%) to the sarco-
lemma. In CD36-KO mice, caffeine-stimulated FABPpm, and FATP1 and
4 translocations were normal, but palmitate transport was blunted
(70%), comparable to the reductions in muscle palmitate oxidation.
Caffeine did not alter the calcium-/calmodulin-dependent protein kinase II
phosphorylation but did increase the phosphorylation of AMPK and
acetyl-CoA carboxylase comparably in WT and CD36-KO.
Conclusion: These studies indicate that sarcolemmal CD36-mediated fatty
acid transport is a primary mediator of the calcium-induced increase in
muscle fatty acid oxidation.
Keywords AMPK, calcium, CaMK, CD36, mitochondria, transport
Skeletal muscle fatty acid utilization is highly
dependent on their uptake from the circulation, as
intramuscular triacylglycerol depots provide only
approx. 10% of the fatty acids destined for b-oxida-
tion (Kiens 2006). CD36 is a well-studied plasma
membrane fatty acid transporter that is important in
lipid handling in a range of tissues, including skeletal
muscle (Bonen et al. 1998, Glatz et al. 2010). CD36
has been found in intracellular depots from which it
can be induced to translocate to the cell surface in
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response to metabolic perturbations, including expo-
sure to insulin, 5-aminoimidazole-4-carboxamide-1-b-
D-ribofuranoside (AICAR) and muscle contraction
(Bonen et al. 2000, Luiken et al. 2002, Jain et al.
2009). Studies using CD36 null mice have established
that the ablation of CD36 has a number of effects on
whole body (Febbraio et al. 1999), cardiac (Habets
et al. 2007) and skeletal muscle fatty acid metabolism
(Bonen et al. 2007), such as a reduction in AICAR-
and insulin-mediated plasmalemmal fatty acid trans-
port and a decrease in AICAR-stimulated fatty acid
oxidation (Bonen et al. 2007).
Calcium release from the sarcoplasmic reticulum
and the subsequent increase in free cytosolic calcium
levels is an essential component of excitation–contrac-
tion coupling in skeletal muscle (Ebashi et al. 1969).
A number of recent studies have examined the meta-
bolic consequences of caffeine-induced calcium release
from the sarcoplasmic reticulum. These studies have
shown that calcium induces an increase in glucose
uptake (Wright et al. 2004, 2005, Jensen et al. 2007),
an effect that could be blocked by inhibiting calcium
release from the ryanodine receptor using dantrolene
(Wright et al. 2004, 2005, Jensen et al. 2007), or by
attenuating calcium/calmodulin kinase II (CaMKII)
signalling (Wright et al. 2004, 2005, Jensen et al.
2007). Calcium release also stimulates fatty acid
metabolism. For example, when cyclopiazonic acid,
an inhibitor of sarcoplasmic/endoplasmic reticulum
calcium ATPase (SERCA), was used to raise cytosolic
calcium, fatty acid esterification was increased but
fatty acid oxidation was not altered (Watt et al.
2003). In contrast, more recently, it was found that
caffeine-induced calcium release stimulated fatty acid
oxidation, an effect that could be blocked by inhibit-
ing either CaMKII signalling (Raney & Turcotte
2008), or calcium/calmodulin kinase kinase (CaMKK)
signalling (Abbott et al. 2009). Clearly, caffeine-
induced calcium release is sufficient to stimulate skele-
tal muscle fatty acid oxidation, but whether this
stimulation is also dependent on caffeine-induced fatty
acid transporter translocation to the sarcolemma has
yet to be firmly established.
Fatty acid transport at the sarcolemma is regulated
by a robust system of proteins. In addition to CD36, a
number of other fatty acid transporters have been iden-
tified, including fatty acid-binding protein (FABPpm)
and fatty acid transport protein (FATP) family mem-
bers, FATP1 and FATP4. While these fatty acid trans-
porters are known to reside on the sarcolemma and to
facilitate fatty acid transport with different efficiencies
(Nickerson et al. 2009), the responses of each trans-
porter to various metabolic stimuli have only recently
been examined. For instance, except for FATP6, all
fatty acid transporters in muscle (FAT/CD36, FAB-
Ppm, FATP1 and 4) are induced to translocate by insu-
lin and by muscle contraction (Jain et al. 2009).
Nevertheless, several studies have suggested that meta-
bolic stimulation of fatty acid oxidation in muscle is
largely dependent on CD36 translocation to the sarco-
lemma (Bonen et al. 2007, Habets et al. 2007). In
addition, caffeine-stimulated fatty acid oxidation has
been linked with the translocation of CD36, but not
FABPpm, to the plasma membrane (Abbott et al.
2009). However, in view of the presence of other fatty
acid transporters in muscle, it is uncertain whether
CD36 accounts primarily for the caffeine-induced
changes in fatty acid oxidation. Moreover, it is
unknown whether other fatty acid transporters (FATP
1 and 4) respond to caffeine stimulation or whether
they can compensate for the loss of CD36 in KO mice.
In addition to being present on the sarcolemma,
CD36 also resides within the mitochondrial compart-
ment (Campbell et al. 2004) where it localizes to the
outer mitochondrial membrane (Smith et al. 2011). In
isolated mitochondria, contraction-mediated fatty acid
oxidation is blunted in mitochondria isolated from
CD36-null muscle (Holloway et al. 2009a), while in
permeabilized muscle fibres, mitochondrial respiration,
using palmitate as a substrate, is significantly reduced
(Smith et al. 2011). It is therefore apparent that CD36
not only regulates fatty acid transport into muscle but
it is also involved in regulating mitochondrial fatty
acid metabolism. Whether the mitochondrial compart-
ment contributes to calcium-induced increase in mus-
cle fatty acid oxidation or whether this is CD36-
dependent is not known.
In this study, we use the CD36-null mouse to exam-
ine the effect of caffeine-induced calcium release on
fatty acid transport and metabolism in skeletal muscle.
Specifically, we sought to determine whether CD36 is
solely responsible for caffeine-induced increases in
fatty acid oxidation or whether other fatty acid trans-
porters are also required. We also examined the con-




Wild-type (WT) and CD36-null (KO) mice (gift, Dr.
M. Febbraio, Cleveland Clinic, Cleveland, Ohio) were
bred on site at the University of Guelph. Female mice
(6–8 weeks of age) were housed in a temperature
(20 °C)-regulated environment with a reversed
12 : 12-h light–dark cycle. Mice had access to stan-
dard laboratory chow and water ad libitum. The ani-
mal care committee at the University of Guelph
approved all experimental procedures.
© 2012 The Authors
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Fatty acid metabolism in isolated soleus muscles
We examined the effects of caffeine on rates of fatty
acid oxidation and esterification in WT-isolated soleus
muscles. In addition, in WT and CD36-null soleus
muscles, we determined the effects of caffeine and the
combined effects of caffeine (3 mM) and an inhibitor of
calcium release (dantrolene, 10 lM in DMSO; 0.3%
DMSO final concentration) on fatty acid oxidation.
To determine palmitate esterification and oxidation,
we used procedures that we have reported previously
(Alkhateeb et al. 2007, Bonen et al. 2007). Briefly,
soleus muscles were obtained from anesthetized mice
(sodium pentobarbital, 6 mg 100 g1 body wt ip;
MTC Pharmaceuticals, Cambridge, ON, Canada). To
saturate the incubation media with oxygen, the incu-
bation media (Media 199; Sigma-Aldrich, Oakville,
ON, Canada) supplemented with 4% BSA (Roche
Diagnostics, Laval, QC, Canada) and 0.5 mM palmi-
tate (Sigma) was pregassed for 40 min (95% O2 and
5% CO2). To allow for recovery of the excised soleus
muscles, they were preincubated in 2 mL of incuba-
tion media in a shaking water bath at 30 °C (100
cycles per min) for 1 h. Thereafter, muscles were
transferred to new pregassed vials containing incuba-
tion media without (control) and with caffeine
(3 mM), and unlabelled (0.5 mM) and 1-14C palmitate
(0.5 lCi mL1) (GE Healthcare Bio-Science, Baie
d’Urfé, QC, Canada) and 4% BSA. For inhibition
studies, it was necessary to pre-expose muscles to
10 lM dantrolene during the last 40 min of the prein-
cubation period. Thereafter, muscles were transferred
to incubation media containing radio-label as before,
and 3 mM caffeine or 3 mM caffeine with 10 lM dan-
trolene dissolved in DMSO (0.3% final concentra-
tion). DMSO (0.3% final concentration) was also
included in control muscles. In all experiments, min-
eral oil was layered on top of the media to prevent
loss of radio-labelled CO2. The incubation was
allowed to proceed for 60 min. Thereafter, muscles
were removed, blotted and were snap-frozen using a
liquid N2 cooled clamp.
The procedures for palmitate oxidation and esterifi-
cation have been used extensively by our group and
have been reported previously in detail (Alkhateeb
et al. 2007, Bonen et al. 2007). Briefly, 14CO2 was
released from the incubating media by the addition of
sulphuric acid (1 M) and was captured (60 min) using
a benzethonium hydroxide trap (Alkhateeb et al.
2007, Bonen et al. 2007). A Folch extraction was used
to obtain lipid and aqueous fractions from homoge-
nized muscle. Water-soluble 14C-labelled intermediate
metabolites were measured in the aqueous phase,
while 14C-palmitate incorporated into muscle triacyl-
glycerol depots was measured in the organic phase
using thin layer chromatography (Alkhateeb et al.
2007, Bonen et al. 2007).
Oxygen consumption in isolated soleus muscle
To determine whether oxygen consumption of WT
and CD36-KO muscles was comparable, we isolated
their soleus muscles as described above. The rate of
oxygen consumption was determined using an Oxy-
graph 2-k (Oroboros Instruments, Innsbruk, Austria).
Soleus muscles were added to the chambers containing
pregassed incubation media (Media 199, supple-
mented with 4% BSA and 0.5 mM palmitate) at 30 °C
and stirring at 750 rpm. Once a basal steady state of
O2 consumption had been achieved, 3 mM caffeine or
media alone (basal) was added to the chamber. After
these additions, the rate of O2 consumption was deter-
mined using OROBOROS DATLAB Software (Oroboros
Instruments).
Palmitate transport and plasma membrane fatty acid
transporter content
To obtain sufficient material for a single determina-
tion of palmitate transport in soleus muscles would
have required the pooling of 30–50 soleus muscles (6–
8 mg each). Therefore, we perfused murine hindlimb
muscles and prepared giant sarcolemmal vesicles as
we have described previously in detail (Bonen et al.
2007, Holloway et al. 2009a). Briefly, hindquarters
were preperfused for 20 min after which the venous
effluent was discarded. This was followed by 60-min
perfusion at 3 mL min1 with a recirculating medium
of 95% O2/5% CO2 Krebs-Henseleit buffer, 7 mM glu-
cose, 0.5 mM palmitate and 4% bovine serum albumin,
pH 7.4, 37 °C. During the 60-min experimental per-
iod, the hindlimb perfusions were performed without
or with caffeine (3 mM). The mouse hindlimb perfusion
preparation is very stable, as we have established previ-
ously in our work (Bonen et al. 2007).
At the end of the perfusion period, giant sarcolem-
mal vesicles were generated as we have previously
described (Bonen et al. 2000, Holloway et al. 2009a,
Jain et al. 2009). Briefly, muscles from the perfused
hindlimb were sectioned into 1 to 3-mm-thick slices
and were incubated for 1 h in 140 mM KCl–10 mM
MOPS [pH 7.4, collagenase type VII (150 U mL1),
aprotinin (1 mg mL1) (Sigma-Aldrich)] while shaking
in a 34 °C water bath. When digestion was complete,
muscle tissue was washed with KCl–MOPS containing
10 mM EDTA. Percoll was added to the supernatant
to give a final concentration of 3.5% Percoll, 28 mM
KCl and 10 lg mL1 aprotinin, and the resulting sus-
pension was placed at the bottom of a density gradi-
ent consisting of a 1-mL KCl–MOPS upper layer and
© 2012 The Authors
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a middle layer of 4% Nycodenz (w/v). Following a
60 g centrifugation for 45 min at room temperature,
the vesicles were harvested from the interface separat-
ing the upper and middle layers, diluted with KCl–
MOPS and recentrifuged for 5 min at 12 000 g at
room temperature. For the determination of fatty acid
transporter protein content, pellets were resuspended
with KCl–MOPS and stored at 80 °C for analysis by
Western blotting.
Palmitate transport rates were measured as we have
described previously in detail (Bonen et al. 2000, Hol-
loway et al. 2009a, Jain et al. 2009). Briefly, 40 lL of
0.1% BSA in KCl–MOPS, containing unlabelled
(15 lM) and radio-labelled 0.3 lCi [3H]-palmitate,
and 0.06 lCi [14C]-mannitol, was added to 40 lL of
vesicle suspension. The incubation was carried out for
15 s. Palmitate uptake was terminated by the addition
of 1.4 mL of ice-cold KCl–MOPS, 2.5 mM HgCl2 and
0.1% BSA. The sample was then centrifuged and the
supernatant fraction was discarded. Thereafter, radio-
activity was determined in the remaining pellet. Non-
specific uptake was measured by adding the stop
solution before the addition of the radio-labelled
palmitate solution.
Palmitate oxidation by isolated mitochondria
The effect of caffeine (3 mM) on mitochondrial fatty
acid oxidation was determined in subsarcolemmal (SS)
and intermyofibrillar (IMF) mitochondria isolated
from perfused murine hindlimb muscles. For practical
reason, it was not possible to do so in isolated murine
soleus muscles, as this would have required pooling of
70–80 murine solei to obtain sufficient SS and IMF
mitochondria for a single determination.
Hindlimb muscle perfusion was conducted as
described above with or without caffeine (3 mM).
After the perfusion period, SS and IMF mitochondria
were isolated from pooled hindlimb muscles using dif-
ferential centrifugation as we (Campbell et al. 2004,
Holloway et al. 2007a) have previously described in
detail. Briefly, muscles were removed and placed in
Buffer 1 (50 mM Tris–HCl, 5 mM MgSO4·7H20, 5 mM
EDTA, 100 mM KCl) at 4 °C. They were trimmed of
all tendons, weighed and then minced with scissors in
1 mL of Buffer 2 (Buffer 1 supplemented with 1.1 mM
ATP). The muscle slurry was resuspended in 9 mL of
Buffer 1 and homogenized for 12 s at 7500 rpm using
a polytron homogenizer. The homogenate was centri-
fuged at 800 g, and the supernatant and pellet were
saved. The supernatant was centrifuged at 9000 g to
pellet the SS mitochondria. To liberate the IMF mito-
chondria, the pellet was resuspended in 4 mL of Buf-
fer 2 and the muscle was digested with subtilisin A
(Sigma) at a concentration of 0.25 lg mg1 wet
weight of muscle for exactly 5 min at 4 °C. When
digestion was complete, the suspension was centri-
fuged at 5000 g, and the pellet was resuspended in
4 mL of Buffer 2. The resuspension was centrifuged at
800 g, and the supernatant was retained and centri-
fuged at 9000 g to pellet IMF mitochondria. Freshly
isolated SS and IMF mitochondria were used to deter-
mine palmitate oxidation in the presence of [1-14C]
palmitate, as we have described previously (Campbell
et al. 2004, Holloway et al. 2007a). Gaseous 14CO2
production and isotopic fixation were determined in a
comparable manner to that described for isolated
soleus muscles (see above).
Western blotting
Protein analysis using soleus muscle homogenates was
performed via Western blotting using standard proce-
dures, as we have previously reported (Bonen et al.
2007, Jain et al. 2009). FAT/CD36 was detected using
mouse monoclonal antibody CD36 (ME542) (Santa
Cruz Biotechnology, Santa Cruz, CA, USA). FATP1
and FATP4 were detected using rabbit polyclonal IgG
antibodies FATP1 (sc25541) and FATP4 (sc5834)
(Santa Cruz). FABPpm was detected using antisera as
we have reported previously (Holloway et al. 2009b,
Jain et al. 2009). Signalling proteins of interest were
detected using antibodies obtained from Cell Signaling
Technology (Danvers, MA, USA), and the antibodies
used were as follows: phospho-CaMKII (Thr286)
Antibody #3361, phospho-AMPKa (Thr172) Antibody
#2531, AMPKa antibody #2532, phospho-Acetyl-CoA
Carboxylase (Ser79) antibody #3661 and Acetyl-CoA
Carboxylase antibody #3662. Immunodetection proce-
dures were carried out as per the manufacturer’s rec-
ommendations. Equal protein loading was confirmed
by Ponceau staining. Protein images were obtained
using enhanced chemiluminescent reagent (Western
Lightning
TM
Plus-ECL; PerkinElmer, Waltham, MA,
USA). Images were acquired using a Chemigenius2
system with GENESNAP software (Syngene, Cambridge,
UK). Band densities were quantified using GENETOOLS
software (Syngene).
Statistics
Data were analysed using two-way analysis of vari-
ance. When appropriate, a Fisher’s LSD post hoc anal-
ysis was used. P  0.05 was considered significant.
All data are reported as mean ± SEM.
Results
In WT soleus muscles, caffeine stimulated palmitate
oxidation (P < 0.05, Fig. 1) while concurrently reduc-
© 2012 The Authors
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ing palmitate esterification (P < 0.05, Fig. 1). This net
reduction in palmitate esterification could not account
fully for the net increase in palmitate oxidation, as the
increase in fatty acid oxidation (D =
+40 nmol g1 60 min1, P < 0.05) was 54% greater
than the reduction in fatty acid esterification
(D = 26 nmol g1 60 min1). Therefore, subsequent
experiments focused on fatty acid oxidation.
Caffeine-induced increase in palmitate oxidation is
blunted in CD36-KO mice
To assess the role of CD36 in the caffeine-stimulated
palmitate oxidation, soleus muscles from WT and
CD36-KO mice were treated with (i) 3 mM caffeine or
(ii) 3 mM caffeine plus dantrolene (10 lM), an inhibi-
tor of calcium release. Caffeine stimulated fatty acid
oxidation in WT muscle (+70%), but this caffeine-
induced effect was 3.3-fold less in CD36-KO muscle
(+21%) (Fig. 2a, P < 0.05).
Pretreatment of muscles with dantrolene inhibited
caffeine-stimulated palmitate oxidation in both WT
and CD36-KO muscles (Fig. 2b). However, in WT
muscle, the dantrolene-mediated inhibition of palmi-
tate oxidation was only partial (43%), while in
CD36-KO muscles, this inhibition was complete
(Fig. 2b).
A comparison of the net changes (D = caf-
feine  basal) in caffeine-stimulated fatty acid oxida-
tion revealed a 70% lower response in the KO mice
(Fig. 2c). This suggests that CD36 accounts for
approx. 70% of caffeine-stimulated palmitate oxida-
tion in soleus muscle.
We also measured basal and caffeine-stimulated
oxygen consumption in isolated soleus muscle from
WT and CD36-KO mice (Fig. 2d). This is important
because a decrease in the metabolic rate in KO muscle
could account for their reduced rate of the palmitate
oxidation. Under basal conditions, O2 consumption
did not differ in WT and KO muscles (P > 0.05). Caf-
feine treatment increased O2 consumption in both WT
(+22%) and KO muscles (+27% KO) (P < 0.05), but
there was no difference between WT and CD36-KO
mice in the caffeine-stimulated rates of O2 consump-
tion.
Caffeine-induced fatty acid transport and fatty acid
transporter translocation
Owing to tissue limitations, it was not possible to
determine fatty acid transport rates or sarcolemmal
fatty acid transport protein content in isolated soleus
muscle. Instead, palmitate transport rates and the
plasma membrane content of fatty acid transporters
CD36, FABPpm, FATP1 and FATP4 were determined
in giant sarcolemmal vesicles prepared from caffeine-
perfused hindlimb muscles. As we have shown previ-
ously, basal fatty acid transport rates were reduced by
14% in KO muscle (Bonen et al. 2007). With caffeine
stimulation, the fatty acid transport rate increased in
both WT (+55%) and KO (+16%) muscles; however,
as with palmitate oxidation, caffeine-induced fatty
acid transport was severely inhibited in KO muscle
(70%, Fig. 3a).
In WT muscle, increases in fatty acid transport rate
were accompanied by concomitant increases in sarco-
lemmal content of all of the fatty acid transporters
measured (CD36: +37%, FABPpm: +26%, FATP1:
+49% and FATP4: +38%, Fig. 3b). In KO muscle, as
expected, CD36 was absent from the sarcolemma.
There was no change in the basal sarcolemmal content
of FATP1 protein; however, sarcolemmal FABPpm
protein levels were reduced somewhat (25%) while
sarcolemmal FATP4 content was increased (+41%) in
KO muscle. Despite these differences in basal
sarcolemmal protein content in KO muscle, the caf-
feine-stimulated increases (%) in FABPpm and FATP1
and 4 were comparable in CD36-KO and WT muscles
(Fig. 3b).
Mitochondrial fatty acid oxidation
To ascertain whether the caffeine-induced increase in
fatty acid oxidation at the whole muscle level was also
associated with a stimulatory effect on mitochondria,
we examined the effects of caffeine on fatty acid
oxidation in isolated mitochondria. Under basal
conditions, the rate of palmitate oxidation by IMF
mitochondria was 80–90% greater than in SS mito-





































Figure 1 Caffeine (3 mM) stimulated palmitate oxidation
and esterification in WT mouse soleus muscle. n = 4–6 mus-
cles per treatment, data are presented as means ± SEM;
*P < 0.05 caffeine vs. basal.
© 2012 The Authors
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the KO animals, the basal rates of palmitate oxidation
by isolated SS (23%) and IMF mitochondria
(21%) were lower than in the WT mice. Perfusing
muscle with caffeine failed to stimulate palmitate oxi-
dation in either SS or IMF mitochondria either in WT
or in KO mice (Fig. 4).
Caffeine-induced phosphorylation of CaMKII, AMPK and
ACC
CaMKII, AMPK and ACC are important kinases in
regulating the response to metabolic challenge in skel-











































































































































Figure 2 The effects of caffeine on
palmitate oxidation and oxygen con-
sumption in isolated soleus muscle of
WT and CD36-KO mice. Panel (a):
effects of caffeine (3 mM) on palmitate
oxidation, n = 8. Panel (b): effects of
caffeine (3 mM) + dantrolene (10 lM) on
palmitate oxidation, n = 8–9. Dashed
line represents the basal rate of palmitate
oxidation shown in panel (a). Panel (c):
Net changes in palmitate oxidation:
D = caffeine  stimulated fatty acid oxi-
dation in individual muscle  average
fatty acid oxidation in nonstimulated
muscles. Panel (d): basal and caffeine-
stimulated oxygen consumption in iso-
lated soleus muscle. n = 5–6 muscles for
each treatment, data are presented as
means ± SEM; *P < 0.05, caffeine vs.
control; **P < 0.05, WT caffeine + dan-
trolene vs. WT caffeine; ***P < 0.05,
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Figure 3 Caffeine stimulated fatty acid transport rates (a) and fatty acid transporter protein content (b) in giant sarcolemmal
vesicles isolated from perfused hindlimb muscle of WT and CD36-KO mice. n = 4–5 for each variable, data are presented as
means ± SEM; *P < 0.05, caffeine vs. basal; **P < 0.05, KO significantly different from respective treatment in WT muscle;
ND, not detected.
© 2012 The Authors
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caffeine-stimulated fatty acid oxidation (Raney &
Turcotte 2008). Given the reduction in caffeine-stimu-
lated palmitate oxidation in CD36-KO mice, we
sought to determine whether the phosphorylation state
of these kinases was also altered. As is common for
the detection of signalling protein activations, the
exposure to caffeine was necessarily brief (15 min)
and therefore the protein expression of CaMKII,
AMPK and ACC was not altered (data not shown).
CaMKII. Total CaMKII did not differ between WT
and KO mice (data not shown). Basal CaMKII phos-
phorylation did not differ in WT and KO mice solei
(P > 0.05). Exposure of soleus muscles to caffeine
failed to induce CaMKII phosphorylation in either
WT or KO mice (P > 0.05, Fig. 5a).
AMPK. Total AMPK did not differ between WT and
KO mice (data not shown). Basal AMPK phosphoryla-
tion did not differ in WT and KO mice solei (P > 0.05).
Caffeine treatment of WT or KO solei increased AMPK
phosphorylation comparably in both WT (+36%) and
CD36-KO mice (+48%) (P < 0.05, Fig. 5b).
ACC. Total ACC did not differ between WT and KO
mice (data not shown). Basal ACC phosphorylation
did not differ in WT and KO mice solei (P > 0.05).
This classical downstream target of AMPK was highly
responsive to caffeine treatment, with ACC phosphor-
ylation increasing in both WT and KO muscles
(P < 0.05, Fig. 5c). However, in WT soleus, caffeine
increased ACC phosphorylation by 81%, while in the
CD36-KO muscles, ACC phosphorylation was
increased significantly less (+40%) (P < 0.05, Fig. 5c).
Discussion
We examined whether caffeine-stimulated fatty acid oxi-
dation was dependent on CD36 translocation to the
plasma membrane. We show that the ablation of CD36
completely abrogated the caffeine-induced upregulation
of fatty acid oxidation, independent of changes in fatty









































Figure 4 Fatty acid oxidation in isolated mitochondria from
caffeine-stimulated hindlimb muscles from WT and CD36-
KO mice. For palmitate oxidation in isolated mitochondria,
the muscles from each hindlimb were pooled for each deter-
mination. n = 5 in each group, data are presented as
means ± SEM; *P < 0.05, SS vs. IMF mitochondria in each
of WT and KO mice; **P < 0.05, KO (basal and caffeine)
vs. WT muscle (basal and caffeine). SS, subsarcolemmal;
IMF, intermyofibrillar.
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Figure 5 Caffeine stimulated CaMKII phosphorylation (Thr286) (a), AMPKa subunit phosphorylation (Thr172) (b), and ACC
phosphorylation (Ser79) (c) in WT and CD36-KO mice. n = 5–6 muscles for each treatment, data are presented as
means ± SEM. Equal quantities of protein were loaded for WT and CD36-KO samples and were routinely confirmed by Pon-
ceau staining. The very brief stimulation with caffeine (15 min) does not alter the protein content of these proteins (data not
shown). *P < 0.05, caffeine vs. basal; **P < 0.05, KO caffeine vs. WT caffeine.
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acid oxidation by isolated SS and IMF mitochondria.
Given the well-established role of CD36 in mediating
fatty acid transport, we conclude that caffeine-stimulated
fatty acid oxidation is regulated, in part, by the CD36-
mediated fatty acid transport across the sarcolemma.
Caffeine induces CD36 translocation to plasma
membrane
Previous studies have established that CD36 is critically
important in heart and skeletal muscle fatty acid
metabolism (Glatz et al. 2010). CD36 is capable of
binding long chain fatty acids (LCFA), and increases in
plasma membrane CD36 are highly correlated with
increases in fatty acid uptake into giant sarcolemmal
vesicles (Glatz et al. 2010). In hearts and muscles of
CD36 null mice, we have previously observed a greatly
impaired rate of fatty acid uptake and oxidation when
these tissues were stimulated with muscle contraction,
AICAR or oligomycin (Bonen et al. 2007, Habets et al.
2007, Jain et al. 2009). Therefore, in the present study,
the blunting of caffeine-stimulated fatty acid oxidation
in CD36-null soleus muscle is likely due to the absence
of CD36 on the plasma membrane. Supporting this
notion are data in the present study and those of
Abbott et al. (2009), which indicate that caffeine induces
the translocation of CD36 to the plasma membrane.
In addition to CD36, translocation of other fatty
acid transporters, namely FABPpm, FATP1 and
FATP4, also occurred in response to caffeine stimula-
tion. Yet, despite the responsiveness of other fatty acid
transporters to caffeine, fatty acid transport and oxida-
tion were reduced considerably in CD36 null mice.
This is somewhat surprising, given the presence of
other fatty acid transporters at the sarcolemma. How-
ever, there is some evidence that CD36 may be required
for other transporters to achieve optimal efficiency. In
particular, FABPpm and CD36 have been shown to
coimmunoprecipitate with one another (Chabowski
et al. 2007, S. Jain, and A. Bonen, unpublished data).
While the association of CD36 with other fatty acid
transporters is not yet firmly established, this could
potentially explain the profound reduction in fatty acid
uptake in the absence of CD36. Taken altogether, these
data further illustrate the essential role of CD36 in skel-
etal muscle fatty acid metabolism at the sarcolemma.
Mitochondrial fatty acid oxidation in response to
caffeine
Many laboratories (Campbell et al. 2004, Distler et al.
2006, Schenk & Horowitz 2006, King et al. 2007, Aoi
et al. 2008, Sebastian et al. 2009), except one (Jeppesen
et al. 2010), have independently confirmed that CD36
is present in mitochondria, where it localizes to the
outer mitochondrial membrane (Smith et al. 2011).
Despite suggestions that these results reflected mito-
chondrial contamination (Jeppesen et al. 2010), many
studies have shown that this is not the case (Bezaire
et al. 2004, Campbell et al. 2004, Schenk & Horowitz
2006, Holloway et al. 2007b, Smith et al. 2011). While
the exact role of CD36 in mitochondria has not been
fully established, we have recently shown, in CD36-KO
mice, that this protein is required for muscle contrac-
tion-induced increases in fatty acid oxidation in isolated
mitochondria (Holloway et al. 2009a) and that mito-
chondrial palmitate, but not palmitoyl-CoA, respiration
is reduced in permeabilized muscle fibres of CD36-KO
mice (Smith et al. 2011). Fatty acid oxidation can also
be regulated by calcium at the level of the mitochon-
dria, as Ca2+ is a well-known effecter on a number of
mitochondrial enzymes. These include rate-limiting
enzymes of the tricarboxylic acid cycle, namely isoci-
trate dehydrogenase (Denton et al. 1978) and a-ketoglu-
tarate dehydrogenase (McCormack & Denton 1979).
However, we did not observe any increase in palmitate
oxidation in mitochondria isolated from caffeine-stimu-
lated skeletal muscle in either CD36-KO or WT mice,
indicating that mitochondrial CD36 is not necessary for
the caffeine-induced increases observed at the whole
muscle level. In this and other studies (Wright et al.
2004, Jensen et al. 2007, Raney & Turcotte 2008,
Abbott et al. 2009) the use of 3 mM caffeine is designed
to release calcium into the cytosol without triggering
muscle contraction (Youn et al. 1991). Given the lack
of a calcium-induced increase in palmitate oxidation in
isolated mitochondria, it appears that the calcium
release elicited by 3 mM caffeine is perhaps too low to
stimulate mitochondrial fatty acid oxidation, while still
inducing the translocation of CD36 to the plasma mem-
brane. It appears therefore that by stimulating CD36-
mediated fatty acid transport into muscle cells, the
resultant increase in intracellular fatty acids is sufficient
to stimulate fatty acid oxidation, without altering the
intrinsic rate of palmitate oxidation by isolated mito-
chondria. This supports early work showing that
increasing fatty acid provision to muscle stimulates their
oxidation (Hickson et al. 1977). Our present findings
further emphasize the key role of fatty acid transport,
mediated by plasma membrane CD36, in the caffeine-
induced upregulation of fatty acid oxidation. Indeed,
the comparable increases in caffeine-stimulated O2 con-
sumption (+27%) and plasma membrane CD36 (+33%)
suggest that the translocation of this fatty acid trans-
porter is tightly associated with muscle respiration rates.
Caffeine-induced signalling
Members of the CaMK family of kinases are activated
by increases in cytosolic calcium/calmodulin (Corco-
© 2012 The Authors
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ran & Means 2001) and are therefore candidates for
the regulation of substrate utilization in response to
calcium release, such as occurs during muscle contrac-
tion. CaMKII activation has been implicated in the
translocation of both glucose and fatty acid transport-
ers (Wright et al. 2004, Jensen et al. 2007, Raney &
Turcotte 2008, Witczak et al. 2010), but the precise
role of CaMKII in this process remains elusive. Unfor-
tunately, the majority of evidence in support of CaM-
KII activation by caffeine relies heavily on the use of
the inhibitor KN-93 (Wright et al. 2004, Jensen et al.
2007, Raney & Turcotte 2008), but recently the speci-
ficity of this inhibitor has been come into question
(Witczak et al. 2010). In the present study, we have
found that treatment with caffeine is not sufficient to
cause CaMKII phosphorylation in mouse soleus mus-
cle. Although there is evidence that muscle contraction
can result in CaMKII phosphorylation in fast-twitch
muscles (Witczak et al. 2010, Egawa et al. 2011), and
in soleus muscle (A. Bonen, X-X. Han, and S. Jain,
unpublished data), only a few studies have provided
direct evidence that this kinase can be activated by
caffeine treatment, and only in fast-twitch muscles
(Wright et al. 2004). Studies examining caffeine
effects on glucose transport in soleus muscle have not
provided evidence that this treatment induces CaMKII
phosphorylation in this slow-twitch muscle (Wright
et al. 2005, Jensen et al. 2007). Taken altogether, it
appears that caffeine-induced CaMKII phosphoryla-
tion may exhibit muscle fibre type specificity. None-
theless, as CD36 translocation to the plasma
membrane did occur, it appears that an increase in
CaMKII phosphorylation may not be required for
CD36 translocation in response to caffeine treatment.
A number of studies have implicated the AMPK sig-
nalling cascade in the regulation of glucose and fatty
acid uptake in response to caffeine treatment (Jensen
et al. 2007, Raney & Turcotte 2008, Abbott et al.
2009, Egawa et al. 2011). We have also found that
caffeine activates AMPK (as well as ACC), but there
are a number of inconsistencies within the literature.
Some have reported that caffeine fails to phosphory-
late total AMPK in incubated soleus muscle (Wright
et al. 2004), a measurement that correlates well with
AMPK activity (Hawley et al. 2010). However, Jensen
et al. (2007) showed that, while there was no change
in total AMPK phosphorylation, caffeine treatment
preferentially phosphorylated the AMPK alpha1
isoform, whereas alpha2 phosphorylation was
unchanged. In epitrochlearis muscle, preferential
activation of the alpha1 isoform occurred with 1 mM
caffeine treatment, but the activity of both isoforms
increased simultaneously with 3 mM caffeine treat-
ment (Egawa et al. 2011). In contrast, others have
shown that caffeine stimulation increases the activity
of the alpha2 isoform and not alpha1 (Raney & Tur-
cotte 2008, Abbott et al. 2009). These conflicting
results (Wright et al. 2004, Jensen et al. 2007, Raney
& Turcotte 2008, Abbott et al. 2009, Egawa et al.
2011) may be due to a number of factors, including
differences in species (rat, Abbott et al. 2009, Raney
& Turcotte 2008, Egawa et al. 2011 vs. mouse, Jen-
sen et al. 2007), experimental models (hindlimb perfu-
sion, Abbott et al. 2009, Raney & Turcotte 2008 vs.
muscle incubation, Jensen et al. 2007, Egawa et al.
2011) or muscle fibre type distribution (fast-twitch,
Abbott et al. 2009, Raney & Turcotte 2008, Egawa
et al. 2011 vs. slow-twitch muscles, Jensen et al.
2007). Although there is some discrepancy in the liter-
ature with respect to the caffeine-induced activation
of AMPK, the observation that caffeine treatment
increases ACC phosphorylation is consistent among
studies (present study, Jensen et al. 2007, Raney &
Turcotte 2008, Abbott et al. 2009, Egawa et al.
2011).
Caffeine-stimulated phosphorylation of ACC was
lower in muscle from KO mice than in WT mice.
Phosphorylation decreases ACC activity (Carling et al.
1987), and the resultant decrease in malonyl-CoA lev-
els relieves the inhibition on CPT-1 and promotes
fatty acid oxidation (McGarry et al. 1978). It is there-
fore possible that a reduction in caffeine-stimulated
ACC phosphorylation in KO mouse muscle contrib-
utes to the overall reduction in fatty acid oxidation.
However, recent studies using muscle-specific ACC2-
KO mice demonstrate that the deletion of ACC2 has
no effect on palmitate oxidation (Olson et al. 2010),
and whether AMPK is the exclusive kinase for ACC is
equivocal (Dzamko et al. 2008). Given the importance
of AMPK activation in the translocation of CD36 to
the sarcolemma (Bonen et al. 2007, Habets et al.
2007, Jain et al. 2009), it appears that in response to
caffeine-induced calcium release, AMPK activation
serves to increase the uptake of fatty acids into
muscle, thereby providing additional substrate to
mitochondria and allowing an increase in fatty acid
oxidation.
Summary
We have used a caffeine treatment to determine
whether an increase in cytosolic calcium increases
soleus muscle fatty acid oxidation in a CD36-depen-
dent manner. We found that the caffeine-induced
increases in (i) palmitate oxidation are blunted in
CD36 null mice (70%), and that this is (ii) likely
due to changes in the sarcolemmal content of CD36,
but (iii) not to intrinsic changes in mitochondrial fatty
acid oxidation. In addition, (iv) we show that the caf-
feine-stimulated increase in CD36 translocation, ACC
© 2012 The Authors
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phosphorylation and fatty acid oxidation occurs in
concert with AMPK activation, which (v) is indepen-
dent of CaMKII phosphorylation. Taken together,
these observations support the critical role of plasma
membrane CD36 in upregulating skeletal muscle fatty
acid oxidation. Specifically, when muscle metabolism
is increased by the release of calcium into the cytosol,
CD36 is translocated to the plasma membrane, which
allows for the uptake of additional fatty acids into
muscle to provide more substrate to mitochondria to
increase the rate of fatty acid oxidation.
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